Answers are grounded in this paper and cite their sources.
Demonstrates severe cytotoxicity of amphotericin B compared to nystatin in heart valve fibroblasts, suggesting amphotericin B should be excluded from allograft disinfection protocols.
Fibroblasts were isolated from fresh porcine aortic cusps and their identity confirmed morphologically and biochemically. The fibroblasts were used to assess the cytotoxicity of nystatin and amphotericin B at room temperature and 4 degrees C, following exposure periods of 4, 24, and 48 h. Except at the highest concentration and the longest exposure period at room temperature, nystatin had little detrimental effect compared with the nystatin free control. In contrast, amphotericin B proved highly cytotoxic. Published protocols for the use of amphotericin B in the disinfection of viable heart valve allografts would result in little residual fibroblast viability. We recommend that amphotericin B is no longer used in this situation.
No takes yet. Share an insight, caveat, or question.
Aguirregoicoa et al. (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: